By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ApoGen Biotechnologies, Inc 

1616 Eastlake Avenue E.
Suite 200
Seattle  Washington  98102   U.S.A.
Phone: 206-957-7300 Fax: 206-957-7399


SEARCH JOBS

ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance. ApoGen’s drug discovery and development efforts are directed toward highly selective and potent small molecule inhibitors of the APOBEC family of enzymes, which are DNA cytosine deaminases and an important endogenous source of DNA mutation in cancer.

YEAR FOUNDED:

1991

LEADERSHIP:

Founders: John Santini, Reuben Harris, Daniel Harki

CEO: Thong Q. Le


Key Statistics


Email:
Ownership: Private

Web Site: ApoGen Biotechnologies
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->